查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024073

癲癇監測設備市場預測—全球產品類型、類別、患者群體、分銷管道、技術、最終用戶和地區分析——2034年

Epilepsy Monitoring Devices Market Forecasts to 2034- Global Analysis By Product (Conventional Devices, Wearable Devices, Implantable Devices and Smart Devices), Type, Patient Type, Distribution Channel, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球癲癇監測設備市場預計到 2026 年將達到 6.8 億美元，並在預測期內以 6.6% 的複合年成長率成長，到 2034 年將達到 11.3 億美元。

癲癇監測設備是一種專門的醫療系統，旨在持續記錄和分析神經活動，用於檢測、診斷和管理癲癇發作。這些設備通常會擷取腦電圖 (EEG) 訊號，以及心率、運動和血氧飽和度等輔助生理參數。它們可用於臨床和家庭環境，以支援準確的癲癇發作分類、治療方案製定和長期疾病管理。先進的解決方案整合了穿戴式技術、雲端連接和人工智慧，可實現即時監測和遠端數據訪問，從而透過及時的臨床干預和個人化護理策略改善患者預後。

異寵越來越受歡迎

隨著人類和獸醫學界對神經系統疾病的認知不斷提高，飼養異寵的現像日益增多，間接推動了癲癇監測設備的成長。這一趨勢反映了人們對先進診斷和監測解決方案的廣泛需求。在人類醫學領域，人們對癲癇的認知不斷提高，加上對連續監測技術的需求日益成長，正在推動相關設備的應用。此外，穿戴式和可攜式腦電圖（EEG）系統的技術進步提高了設備的易用性，使得這些設備在醫院和居家照護環境中得到廣泛應用。

嚴格的法規和進口限制

嚴格的法規結構和進口限制給市場帶來了巨大挑戰。尤其對於醫用級腦電圖系統和穿戴式技術而言，嚴格的核准流程會延長產品上市時間，並增加製造商的營運成本。此外，各國監管標準的差異也使全球部署策略更加複雜。對敏感醫療設備的進口限制進一步限制了發展中地區的供應，阻礙了病患的就醫。這些因素共同抑制了創新，延緩了產品上市，並為尋求進入市場的中小企業設置了障礙。

都市化和生活方式的改變

快速的都市化和生活方式的改變為市場創造了巨大的成長機會。壓力增大、久坐不動的生活方式以及環境變化導致包括癲癇在內的神經系統疾病盛行率上升。此外，都市區對先進醫療技術的認知度更高，也更容易獲得這些技術，從而推動了持續監測解決方案的需求。同時，都市區醫療基礎設施的改善、可支配收入的增加以及遠距遠端醫療服務的擴展，也促進了穿戴式和家用癲癇監測設備的普及。

實施成本高且需要專門的照護。

癲癇監測設備的高成本和所需的專業護理對市場成長構成重大威脅。包括長期腦電圖（EEG）和人工智慧整合設備在內的先進監測系統，需要大量的初始投資和持續的維護成本。此外，準確的診斷和數據解讀需要經驗豐富的神經科和訓練有素的專家，而這些人才並非在所有地區都能輕易獲得。這些成本和專業技能方面的障礙限制了這些設備的普及，尤其是在中低收入國家，這可能會阻礙醫療機構投資這些先進技術。

新冠疫情的影響：

新冠疫情對市場產生了複雜的影響。雖然由於門診就診和擇期手術的中斷，臨床環境中設備的使用量暫時下降，但對遠端監測解決方案的需求卻顯著增加。患者和醫療服務提供者更加依賴穿戴式裝置和遠端醫療平台來確保醫療服務的連續性。這種轉變加速了家庭監測技術的普及和數位醫療的整合。即使在後疫情時代，市場仍受益於去中心化、以病人為中心的醫療模式的轉變。

在預測期內，兒童領域預計將佔據最大的市場佔有率。

由於兒童癲癇發生率高，且迫切需要早期診斷和持續監測，預計兒童領域在預測期內將佔據最大的市場佔有率。兒童患者通常需要長期觀察，以便準確區分癲癇發作類型並最佳化治療方案。家長意識的提高、兒童神經科服務的可及性改善以及兒童穿戴式監測設備的進步，都進一步推動了該領域的成長，從而確保更好的疾病管理和更高的生活品質。

在預測期內，神經科中心細分市場預計將呈現最高的複合年成長率。

在預測期內，由於癲癇診斷和治療的專業化程度不斷提高，神經科中心預計將呈現最高的成長率。這些中心配備了先進的腦電圖（EEG）監測系統，並聘請了能夠處理複雜神經系統病例的資深專家。轉診至專科中心的患者數量增加，以及對專用神經科基礎設施投資的加大，正在推動該領域的擴張。此外，人工智慧診斷等先進技術的應用提高了效率和準確性，進一步刺激了市場需求。

市佔率最大的地區：

在預測期內，亞太地區預計將佔據最大的市場佔有率，這主要得益於其龐大的人口基數、神經系統疾病盛行率的上升以及醫療基礎設施的不斷完善。政府主導的旨在改善醫療服務可近性的舉措日益增多，以及公眾對癲癇診斷和治療認知的不斷提高，都在推動對監測設備的需求。此外，醫療設施的擴張、醫療支出的成長以及中國和印度等新興經濟體的存在，也顯著增強了該地區的市場主導地位。

複合年成長率最高的地區：

在預測期內，北美地區預計將呈現最高的複合年成長率，這主要得益於其先進的醫療保健體系、創新醫療技術的高普及率以及主要市場參與者的強大影響力。該地區受益於活躍的研發活動、對數位醫療不斷成長的投資以及穿戴式監測設備的廣泛應用。此外，有利的報銷政策、對神經系統疾病日益成長的認知以及對遠端患者監護解決方案不斷成長的需求，都在加速全部區域的市場成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球癲癇監測設備市場：依產品分類

  • 傳統設備
  • 穿戴式裝置
  • 嵌入式裝置
  • 智慧型裝置

第6章 全球癲癇監測設備市場：依類型分類

  • 局部性癲癇發作
  • 整體癲癇發作

第7章 全球癲癇監測設備市場：依病患類型分類

  • 兒童
  • 成人
  • 老年人

第8章 全球癲癇監測設備市場：依通路分類

  • 零售銷售
  • 線上銷售
  • 直接競標
  • 其他分銷管道

第9章 全球癲癇監測設備市場：依技術分類

  • 腦電圖（EEG）
  • 加速度測量
  • 迷走神經刺激術（VNS）
  • 深部腦部刺激（DBS）
  • 反應性神經刺激（RNS）

第10章 全球癲癇監測設備市場：依最終用戶分類

  • 醫院和診所
  • 神經科中心
  • 診斷中心
  • 門診手術中心（ASC）
  • 居家醫療環境
  • 研究機構

第11章 全球癲癇監測設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Natus Medical, Inc.
  • Compumedics Limited
  • Nihon Kohden Corporation
  • Medtronic plc
  • Koninklijke Philips NV
  • GE HealthCare
  • Masimo Corporation
  • Cadwell Industries, Inc.
  • NeuroPace, Inc.
  • Empatica Inc.
  • BioSerenity
  • BrainScope Company, Inc.
  • Seer Medical
  • Stratus
  • Dragerwerk AG & Co. KGaA
Product Code: SMRC35285

According to Stratistics MRC, the Global Epilepsy Monitoring Devices Market is accounted for $0.68 billion in 2026 and is expected to reach $1.13 billion by 2034 growing at a CAGR of 6.6% during the forecast period. Epilepsy monitoring devices are specialized medical systems designed to continuously record and analyze neurological activity to detect, diagnose, and manage epileptic seizures. These devices typically capture electroencephalography (EEG) signals, along with complementary physiological parameters such as heart rate, movement, and oxygen levels. They are used in both clinical and home settings to support accurate seizure classification, treatment planning, and long-term disease management. Advanced solutions integrate wearable technology, cloud connectivity, and artificial intelligence to enable real time monitoring, remote data access, and improved patient outcomes through timely clinical intervention and personalized care strategies.

Market Dynamics:

Driver:

Rising adoption of exotic pets

The rising adoption of exotic pets has indirectly contributed to the growth of epilepsy monitoring devices, as awareness of neurological conditions across both human and veterinary domains increases. This trend reflects a broader shift toward advanced diagnostic and monitoring solutions. In human healthcare, growing awareness of epilepsy, coupled with increased demand for continuous monitoring technologies, is driving device adoption. Additionally, technological advancements in wearable and portable EEG systems are enhancing accessibility, encouraging both hospitals and homecare settings to adopt these devices widely.

Restraint:

Strict regulations and import restrictions

Strict regulatory frameworks and import restrictions pose significant challenges to the market. Compliance with stringent approval processes, particularly for medical-grade EEG systems and wearable technologies, increases time-to-market and operational costs for manufacturers. In addition, varying regulatory standards across countries complicate global expansion strategies. Import limitations on sensitive medical equipment further restrict availability in developing regions, limiting patient access. These factors collectively hinder innovation, delay product launches, and create barriers for small and medium sized enterprises entering the market.

Opportunity:

Urbanization and lifestyle shifts

Rapid urbanization and evolving lifestyle patterns present strong growth opportunities for the market. Increasing stress levels, sedentary habits, and changing environmental conditions have contributed to a higher prevalence of neurological disorders, including epilepsy. Urban populations also demonstrate greater awareness and access to advanced healthcare technologies, driving demand for continuous monitoring solutions. Furthermore, improved healthcare infrastructure, rising disposable incomes and expanding telemedicine services in urban areas support the adoption of wearable and home based epilepsy monitoring devices.

Threat:

High cost of ownership and specialized care

The high cost of epilepsy monitoring devices and the need for specialized care present a notable threat to market growth. Advanced monitoring systems, including long-term EEG and AI-integrated devices, involve significant upfront investment and maintenance expenses. Additionally, accurate diagnosis and data interpretation require skilled neurologists and trained professionals, which may not be readily available in all regions. These cost and expertise barriers limit adoption, particularly in low and middle income countries, and may discourage healthcare facilities from investing in such advanced technologies.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the market. While disruptions in hospital visits and elective procedures temporarily reduced device utilization in clinical settings, the demand for remote monitoring solutions increased significantly. Patients and healthcare providers increasingly relied on wearable devices and telehealth platforms to ensure continuity of care. This shift accelerated the adoption of home-based monitoring technologies and digital health integration. Post-pandemic, the market continues to benefit from this transition toward decentralized and patient-centric care models.

The paediatric segment is expected to be the largest during the forecast period

The paediatric segment is expected to account for the largest market share during the forecast period, due to the high prevalence of epilepsy in children and the critical need for early diagnosis and continuous monitoring. Pediatric patients often require long-term observation to accurately classify seizure types and optimize treatment plans. Increasing parental awareness, improved access to pediatric neurology services and advancements in child-friendly wearable monitoring devices further supports segment growth, ensuring better disease management and improved quality of life.

The neurology centres segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurology centres segment is predicted to witness the highest growth rate, due to increasing specialization of epilepsy diagnosis and treatment. These centers are equipped with advanced EEG monitoring systems and skilled professionals capable of handling complex neurological cases. Growing referrals to specialized centers, along with rising investments in dedicated neurological infrastructure, are driving segment expansion. Additionally, the integration of advanced technologies such as AI-based diagnostics enhances efficiency and accuracy, further boosting demand.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its large population base, rising prevalence of neurological disorders, and improving healthcare infrastructure. Increasing government initiatives to enhance healthcare accessibility, coupled with growing awareness of epilepsy diagnosis and treatment, are driving demand for monitoring devices. Additionally, expanding medical facilities, rising healthcare expenditure, and the presence of emerging economies such as China and India contribute significantly to regional market dominance.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to advanced healthcare systems, high adoption of innovative medical technologies, and strong presence of key market players. The region benefits from robust research and development activities, increasing investment in digital health, and widespread use of wearable monitoring devices. Furthermore, favorable reimbursement policies, growing awareness of neurological disorders, and increasing demand for remote patient monitoring solutions are accelerating market growth across the region.

Key players in the market

Some of the key players in Epilepsy Monitoring Devices Market include Natus Medical, Inc., Compumedics Limited, Nihon Kohden Corporation, Medtronic plc, Koninklijke Philips N.V., GE HealthCare, Masimo Corporation, Cadwell Industries, Inc., NeuroPace, Inc., Empatica Inc., BioSerenity, BrainScope Company, Inc., Seer Medical, Stratus and Dragerwerk AG & Co. KGaA

Key Developments:

In March 2026, Medtronic plc expanded its multiyear alliance with GE HealthCare to accelerate next-generation innovation, integrate advanced patient monitoring technologies, and enhance clinical solutions, enabling more efficient workflows, improved patient outcomes, and broader access to connected, data-driven healthcare systems globally.

In February 2026, Medtronic announced its intent to acquire CathWorks for up to $585 million, strengthening its cardiovascular portfolio. The deal builds on their 2022 partnership and integrates AI-based FFRangio technology to enhance coronary disease diagnosis and treatment, pending regulatory approval.

Products Covered:

  • Conventional Devices
  • Wearable Devices
  • Implantable Devices
  • Smart Devices

Types Covered:

  • Focal Seizures
  • Generalized Seizures

Distribution Channels Covered:

  • Retail Sales
  • Online Sales
  • Direct Tenders
  • Other Distribution Channels

Technologies Covered:

  • Electroencephalography (EEG)
  • Accelerometry
  • Vagus Nerve Stimulation (VNS)
  • Deep Brain Stimulation (DBS)
  • Responsive Neurostimulation (RNS)

End Users Covered:

  • Hospitals & Clinics
  • Neurology Centres
  • Diagnostic Centres
  • Ambulatory Surgical Centres (ASCs)
  • Homecare Settings
  • Research Institutes

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Epilepsy Monitoring Devices Market, By Product

  • 5.1 Conventional Devices
  • 5.2 Wearable Devices
  • 5.3 Implantable Devices
  • 5.4 Smart Devices

6 Global Epilepsy Monitoring Devices Market, By Type

  • 6.1 Focal Seizures
  • 6.2 Generalized Seizures

7 Global Epilepsy Monitoring Devices Market, By Patient Type

  • 7.1 Paediatric
  • 7.2 Adult
  • 7.3 Geriatric

8 Global Epilepsy Monitoring Devices Market, By Distribution Channel

  • 8.1 Retail Sales
  • 8.2 Online Sales
  • 8.3 Direct Tenders
  • 8.4 Other Distribution Channels

9 Global Epilepsy Monitoring Devices Market, By Technology

  • 9.1 Electroencephalography (EEG)
  • 9.2 Accelerometry
  • 9.3 Vagus Nerve Stimulation (VNS)
  • 9.4 Deep Brain Stimulation (DBS)
  • 9.5 Responsive Neurostimulation (RNS)

10 Global Epilepsy Monitoring Devices Market, By End User

  • 10.1 Hospitals & Clinics
  • 10.2 Neurology Centres
  • 10.3 Diagnostic Centres
  • 10.4 Ambulatory Surgical Centres (ASCs)
  • 10.5 Homecare Settings
  • 10.6 Research Institutes

11 Global Epilepsy Monitoring Devices Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Natus Medical, Inc.
  • 14.2 Compumedics Limited
  • 14.3 Nihon Kohden Corporation
  • 14.4 Medtronic plc
  • 14.5 Koninklijke Philips N.V.
  • 14.6 GE HealthCare
  • 14.7 Masimo Corporation
  • 14.8 Cadwell Industries, Inc.
  • 14.9 NeuroPace, Inc.
  • 14.10 Empatica Inc.
  • 14.11 BioSerenity
  • 14.12 BrainScope Company, Inc.
  • 14.13 Seer Medical
  • 14.14 Stratus
  • 14.15 Dragerwerk AG & Co. KGaA

List of Tables

  • Table 1 Global Epilepsy Monitoring Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Epilepsy Monitoring Devices Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Epilepsy Monitoring Devices Market Outlook, By Conventional Devices (2023-2034) ($MN)
  • Table 4 Global Epilepsy Monitoring Devices Market Outlook, By Wearable Devices (2023-2034) ($MN)
  • Table 5 Global Epilepsy Monitoring Devices Market Outlook, By Implantable Devices (2023-2034) ($MN)
  • Table 6 Global Epilepsy Monitoring Devices Market Outlook, By Smart Devices (2023-2034) ($MN)
  • Table 7 Global Epilepsy Monitoring Devices Market Outlook, By Type (2023-2034) ($MN)
  • Table 8 Global Epilepsy Monitoring Devices Market Outlook, By Focal Seizures (2023-2034) ($MN)
  • Table 9 Global Epilepsy Monitoring Devices Market Outlook, By Generalized Seizures (2023-2034) ($MN)
  • Table 10 Global Epilepsy Monitoring Devices Market Outlook, By Patient Type (2023-2034) ($MN)
  • Table 11 Global Epilepsy Monitoring Devices Market Outlook, By Paediatric (2023-2034) ($MN)
  • Table 12 Global Epilepsy Monitoring Devices Market Outlook, By Adult (2023-2034) ($MN)
  • Table 13 Global Epilepsy Monitoring Devices Market Outlook, By Geriatric (2023-2034) ($MN)
  • Table 14 Global Epilepsy Monitoring Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 15 Global Epilepsy Monitoring Devices Market Outlook, By Retail Sales (2023-2034) ($MN)
  • Table 16 Global Epilepsy Monitoring Devices Market Outlook, By Online Sales (2023-2034) ($MN)
  • Table 17 Global Epilepsy Monitoring Devices Market Outlook, By Direct Tenders (2023-2034) ($MN)
  • Table 18 Global Epilepsy Monitoring Devices Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 19 Global Epilepsy Monitoring Devices Market Outlook, By Technology (2023-2034) ($MN)
  • Table 20 Global Epilepsy Monitoring Devices Market Outlook, By Electroencephalography (EEG) (2023-2034) ($MN)
  • Table 21 Global Epilepsy Monitoring Devices Market Outlook, By Accelerometry (2023-2034) ($MN)
  • Table 22 Global Epilepsy Monitoring Devices Market Outlook, By Vagus Nerve Stimulation (VNS) (2023-2034) ($MN)
  • Table 23 Global Epilepsy Monitoring Devices Market Outlook, By Deep Brain Stimulation (DBS) (2023-2034) ($MN)
  • Table 24 Global Epilepsy Monitoring Devices Market Outlook, By Responsive Neurostimulation (RNS) (2023-2034) ($MN)
  • Table 25 Global Epilepsy Monitoring Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 26 Global Epilepsy Monitoring Devices Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 27 Global Epilepsy Monitoring Devices Market Outlook, By Neurology Centres (2023-2034) ($MN)
  • Table 28 Global Epilepsy Monitoring Devices Market Outlook, By Diagnostic Centres (2023-2034) ($MN)
  • Table 29 Global Epilepsy Monitoring Devices Market Outlook, By Ambulatory Surgical Centres (ASCs) (2023-2034) ($MN)
  • Table 30 Global Epilepsy Monitoring Devices Market Outlook, By Homecare Settings (2023-2034) ($MN)
  • Table 31 Global Epilepsy Monitoring Devices Market Outlook, By Research Institutes (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.